Literature DB >> 194845

Comparative studies on adult donor lymphocytes infected by EB virus in vivo or in vitro: origin of transformed cells arising in co-cultures with foetal lymphocytes.

A B Rickinson, S Finerty, M A Epstein.   

Abstract

Co-cultures were set up between equal numbers of mononuclear cells from the blood of EB virus-infected individuals, either acute IM patients or healthy seropositive adult donors, and foetal cord blood mononuclear cells of the opposite sex. The cell lines arising in the co-cultures were of mixed origin, with foetal cells predominating in many cases. In contrast, when mononuclear cells from seronegative adult donors were first infected with EB virus in vitro and then 5 to 12 days later co-cultured with a large excess of foetal cells of the opposite sex, the cell lines which arose were almost exclusively derived from the adult donor despite the fact that a small minority of the virus-infected adult cells released infectious virus capable of transforming the co-cultivated foetal cells. The experiments suggest that EB virus-infected cells present in the blood of IM patients and seropositive donors do not possess the capacity for unlimited in vitro growth shown by seronegative adult donor lymphocytes experimentally infected with the virus.

Entities:  

Mesh:

Year:  1977        PMID: 194845     DOI: 10.1002/ijc.2910190606

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Evolutionary dynamics of genetic variation in Epstein-Barr virus isolates of diverse geographical origins: evidence for immune pressure-independent genetic drift.

Authors:  R Khanna; R W Slade; L Poulsen; D J Moss; S R Burrows; J Nicholls; J M Burrows
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter.

Authors:  Chia Chi Sun; David A Thorley-Lawson
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

3.  Unusually high frequency of Epstein-Barr virus genetic variants in Papua New Guinea that can escape cytotoxic T-cell recognition: implications for virus evolution.

Authors:  J M Burrows; S R Burrows; L M Poulsen; T B Sculley; D J Moss; R Khanna
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

4.  Morphologic and immunophenotypic characterization of a cell line derived from liver tissue with Epstein-Barr virus associated post-transplant lymphoproliferative disease.

Authors:  P S Randhawa; A Zeevi; C Alvares; S Gollin; R Agostini; E Yunis; S Saidman; L Contis; A J Demetris; M A Nalesnik
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-06       Impact factor: 2.416

5.  Epstein-Barr virus-carrying B cells are large, surface IgM, IgD-bearing cells in normal individuals and acute malaria patients.

Authors:  K M Lam; H Whittle; M Grzywacz; D H Crawford
Journal:  Immunology       Date:  1994-07       Impact factor: 7.397

6.  The effect of Epstein-Barr virus Latent Membrane Protein 2 expression on the kinetics of early B cell infection.

Authors:  Laura R Wasil; Monica J Tomaszewski; Aki Hoji; David T Rowe
Journal:  PLoS One       Date:  2013-01-08       Impact factor: 3.240

7.  Characteristics of Epstein-Barr virus activation of human B lymphocytes.

Authors:  A G Bird; S Britton; I Ernberg; K Nilsson
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

8.  Early events associated with infection of Epstein-Barr virus infection of primary B-cells.

Authors:  Sabyasachi Halder; Masanao Murakami; Subhash C Verma; Pankaj Kumar; Fuming Yi; Erle S Robertson
Journal:  PLoS One       Date:  2009-09-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.